Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 29, 2020 at 02:29 pm IST
Share
Beihai Gofar Marine Biological Industry Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 181.341 million compared to CNY 183.032 million a year ago. Operating loss was CNY 3.305 million compared to CNY 6.309 million a year ago. Net loss was CNY 5.301 million compared to CNY 6.132 million a year ago. Basic loss per share from continuing operations was CNY 0.01 compared to CNY 0.013 a year ago.
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.